XPENG INC.
XPEV
Sync financial data to generate a health grade for this company.
Analytical Summary
On an absolute basis, XPENG INC. shows solid but mixed fundamentals. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.
info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ | FY 2021 Dec 31, 2020 20-F ↗ |
|---|---|---|---|---|---|
| EPS Growth YoY (%) |
80.4%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
48.7%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M | — | — |
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ | FY 2021 Dec 31, 2020 20-F ↗ |
|---|---|---|---|---|---|
| Operating Margin (%) (%) | — | — | — | — |
-73.5%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-712%)
|
| Profit Margin (%) (%) | — | — | — | — |
-46.7%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-684%)
|
| FCF Margin (%) (%) | — | — | — | — |
-16.2%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
| FCF / Net Income (x) | — | — | — | — |
0.35x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ | FY 2021 Dec 31, 2020 20-F ↗ |
|---|---|---|---|---|---|
| Return on Invested Capital (%) | — | — | — | — |
-9.4%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
| Return on Capital (%) (%) | — | — | — | — |
-9.6%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
| Return on Common Equity (%) (%) | — | — | — | — |
-7.9%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-140%)
|
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ | FY 2021 Dec 31, 2020 20-F ↗ |
|---|---|---|---|---|---|
| Debt to Equity (x) | — | — | — | — |
0.05x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-94%)
|
| Interest Coverage (x) | — | — | — | — |
-191.24x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
| Net Debt (USD) | — | — | — | — | $-4.20B |
| Debt / EBITDA (x) | — | — | — | — |
-0.44x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
| Metric | FY 2025 Dec 31, 2025 20-F ↗ | FY 2024 Dec 31, 2024 20-F ↗ | FY 2023 Dec 31, 2023 20-F ↗ | FY 2022 Dec 31, 2022 20-F ↗ | FY 2021 Dec 31, 2020 20-F ↗ |
|---|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | — | — | — | — | $895.68M |
| Depreciation Expense (USD) | — | — | — | — | $46.43M |
| Net Income, GAAP (USD) | — | — | — | — | $-418.70M |
| Operating Cash Flow (USD) | — | — | — | — | $-21.42M |
Secondary lens
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Unavailable
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Benchmarks unavailable
Verdicts use absolute quality thresholds, not peer comparison — only 0 comparable companies are currently available for ranking.
Use Statement Evidence firstCompare XPEV with peers
Stack XPEV against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 5 years · 1 quarters